Mechanism underlying anti-apoptotic activity of a (−)deprenyl-related propargylamine, rasagiline
暂无分享,去创建一个
[1] M. Carrillo,et al. Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat. , 2000, Life sciences.
[2] M. Naoi,et al. Cell death of dopamine neurons in aging and Parkinson’s disease , 1999, Mechanisms of Ageing and Development.
[3] J. Qi,et al. L‐deprenyl potentiates NGF‐induced changes in superoxide dismutase mRNA in PC12 cells , 1998, Journal of neuroscience research.
[4] S. Cohen,et al. Sparing by Rasagiline (Tvp-1012) of Cholinergic Functions and Behavior in the Postnatal Anoxia Rat , 1998, Pharmacology Biochemistry and Behavior.
[5] M. Naoi,et al. (−)‐Deprenyl Protects Human Dopaminergic Neuroblastoma SH‐SY5Y Cells from Apoptosis Induced by Peroxynitrite and Nitric Oxide , 1998, Journal of neurochemistry.
[6] D. Chuang,et al. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. , 1998, Molecular pharmacology.
[7] T. Takeshima,et al. Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor , 1998, Neuroreport.
[8] P. Fürst,et al. Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 andR-(−)-Deprenyl* , 1998, The Journal of Biological Chemistry.
[9] W. Tatton,et al. Mitochondrial Membrane Potential and Nuclear Changes in Apoptosis Caused by Serum and Nerve Growth Factor Withdrawal: Time Course and Modification by (−)-Deprenyl , 1998, The Journal of Neuroscience.
[10] A. Lees,et al. Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.
[11] M. Naoi,et al. An Endogenous Dopaminergic Neurotoxin, N‐Methyl‐(R)‐Salsolinol, Induces DNA Damage in Human Dopaminergic Neuroblastoma SH‐SY5Y Cells , 1997, Journal of neurochemistry.
[12] Y. Agid,et al. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. , 1997, Histology and histopathology.
[13] H. Moriwaki,et al. Rapid loss in the mitochondrial membrane potential during geranylgeranoic acid-induced apoptosis. , 1997, Biochemical and biophysical research communications.
[14] W. Tatton. Modulation of gene expression rather than monoamine oxidase inhibition , 1996, Neurology.
[15] J. Finberg,et al. Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo , 1996, Journal of neurochemistry.
[16] D. Chuang,et al. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Hubble,et al. The effect of deprenyl and levodopa on the progression of Parkinson's disease , 1995, Annals of neurology.
[18] M. Youdim. The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction , 1995, Acta psychiatrica Scandinavica. Supplementum.
[19] D. Holland,et al. (−)‐Deprenyl Reduces PC12 Cell Apoptosis by Inducing New Protein Synthesis , 1994, Journal of neurochemistry.
[20] M. Brin,et al. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.
[21] G. Engberg,et al. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons. , 1991, The Journal of pharmacology and experimental therapeutics.
[22] M. Youdim,et al. TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE B , 1981, British journal of pharmacology.
[23] I. Fridovich,et al. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.
[24] R. F. Beers,et al. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. , 1952, The Journal of biological chemistry.
[25] A. Kupsch,et al. Chronic TVP-1012 (rasagiline) dose--activity response of monoamine oxidases A and B in the brain of the common marmoset. , 1998, Journal of neural transmission. Supplementum.
[26] Z. Speiser,et al. Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. , 1998, Journal of neural transmission. Supplementum.
[27] M. Youdim,et al. Pharmacology and neuroprotective properties of rasagiline. , 1996, Journal of neural transmission. Supplementum.
[28] M. Carrillo,et al. (-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. , 1991, Life sciences.